Carlos A Amado
Overview
Explore the profile of Carlos A Amado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amado C, Ghadban C, Manrique A, Osorio J, Ruiz de Infante M, Perea R, et al.
Intern Emerg Med
. 2024 May;
19(6):1567-1575.
PMID: 38722501
Monocyte distribution width (MDW) has been associated with inflammation and poor prognosis in various acute diseases. Chronic obstructive pulmonary disease (COPD) exacerbations (ECOPD) are associated with mortality. The objective of...
2.
Amado C, Martin-Audera P, Aguero J, Ferrer-Pargada D, Josa Laorden B, Boucle D, et al.
Chron Respir Dis
. 2023 Dec;
20:14799731231220058.
PMID: 38112134
Background: Chronic obstructive pulmonary disease (COPD) exacerbation (ECOPD) alters the natural course of the disease. To date, only C-reactive protein has been used as a biomarker in ECOPD, but it...
3.
Golpe R, Figueira-Goncalves J, Esteban C, Amado C, Dacal-Rivas D, Veiga I
Arch Bronconeumol
. 2023 Oct;
59(12):846-847.
PMID: 37827950
No abstract available.
4.
Amado C, Martin-Audera P, Aguero J, Lavin B, Guerra A, Boucle D, et al.
Front Med (Lausanne)
. 2023 Feb;
10:1100211.
PMID: 36844198
Background: MOTS-c and Romo1 are mitochondrial peptides that are modulated by oxidative stress. No previous studies have explored circulating levels of MOTS-c in patients with chronic obstructive pulmonary disease (COPD)....
5.
Amado C, Martin-Audera P, Aguero J, Lavin B, Guerra A, Munoz P, et al.
Sci Rep
. 2022 Oct;
12(1):17315.
PMID: 36243733
Mitokines (Humanin (HN), GDF15 and FGF21) are produced as a result of mitochondrial dysfunction and may have major roles in chronic inflammation, malnutrition and exercise capacity in people with COPD....
6.
Lopez-Campos J, Jimenez-Ruiz C, Meneses Petersen E, Rabade Castedo C, Asensio Sanchez S, Vaquero Lozano P, et al.
Arch Bronconeumol
. 2022 Mar;
58(3):264-267.
PMID: 35312574
No abstract available.
7.
Golpe R, Figueira-Goncalves J, Amado C, Martin-Audera P, Esteban C, Garcia-Talavera I, et al.
Respir Med Res
. 2021 Dec;
81:100879.
PMID: 34954488
Background: The 2-dimensional, 4-quadrant 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPD A-D assessment tool (GOLD) does not include lung function variables to classify patients into different risk...
8.
Amado C, Munoz P, Garcia-Unzueta M, Aguero J, Tello S, Fueyo P, et al.
Respir Med
. 2021 Apr;
182:106416.
PMID: 33894440
Background: Hypovitaminosis D has been linked to deterioration in clinical parameters and lung function in COPD. As a response to low levels of vitamin D serum Parathyroid Hormone (iPTH) is...
9.
10.
Amado C, Garcia-Unzueta M, Farinas M, Santos F, Ortiz M, Munoz-Cacho P, et al.
BMC Pulm Med
. 2016 Jul;
16(1):99.
PMID: 27392908
Background: Vitamin D and vitamin D dependent antimicrobial peptides such as Cathelicidin (LL-37) and β-defensin 2 have an important role in innate and adaptative immunity, but their role in pleural...